Kaneto Hideaki, Matsuoka Taka-aki
Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577, Matsushima, Kurashiki 701-0192, Japan.
Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Int J Mol Sci. 2015 Mar 18;16(3):6281-97. doi: 10.3390/ijms16036281.
A variety of pancreatic transcription factors including PDX-1 and MafA play crucial roles in the pancreas and function for the maintenance of mature β-cell function. However, when β-cells are chronically exposed to hyperglycemia, expression and/or activities of such transcription factors are reduced, which leads to deterioration of b-cell function. These phenomena are well known as β-cell glucose toxicity in practical medicine as well as in the islet biology research area. Here we describe the possible mechanism for β-cell glucose toxicity found in type 2 diabetes. It is likely that reduced expression levels of PDX-1 and MafA lead to suppression of insulin biosynthesis and secretion. In addition, expression levels of incretin receptors (GLP-1 and GIP receptors) in β-cells are decreased, which likely contributes to the impaired incretin effects found in diabetes. Taken together, down-regulation of insulin gene transcription factors and incretin receptors explains, at least in part, the molecular mechanism for β-cell glucose toxicity.
包括PDX-1和MafA在内的多种胰腺转录因子在胰腺中发挥着关键作用,并对维持成熟β细胞功能起作用。然而,当β细胞长期暴露于高血糖环境时,这些转录因子的表达和/或活性会降低,从而导致β细胞功能恶化。在临床医学以及胰岛生物学研究领域,这些现象被称为β细胞葡萄糖毒性。在此,我们描述了2型糖尿病中发现的β细胞葡萄糖毒性的可能机制。PDX-1和MafA表达水平降低可能导致胰岛素生物合成和分泌受到抑制。此外,β细胞中肠促胰岛素受体(GLP-1和GIP受体)的表达水平下降,这可能导致糖尿病患者中肠促胰岛素效应受损。综上所述,胰岛素基因转录因子和肠促胰岛素受体的下调至少部分解释了β细胞葡萄糖毒性的分子机制。